Cancer Research AACR Conference on Molecular Diagnostics - 2008  Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Roth, R. B.
Right arrow Articles by Samson, L. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Roth, R. B.
Right arrow Articles by Samson, L. D.
[Cancer Research 62, 656-660, February 1, 2002]
© 2002 American Association for Cancer Research


Advances in Brief

3-Methyladenine DNA Glycosylase-deficient Aag Null Mice Display Unexpected Bone Marrow Alkylation Resistance1

Richard B. Roth and Leona D. Samson2

Division of Bioengineering and Environmental Health, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139

Most cells deficient in 3-methyladenine (3MeA) DNA glycosylase become sensitive to the lethal and clastogenic effects of alkylating agents. Surprisingly, myeloid progenitor bone marrow (BM) cells derived from Aag -/- mice were more resistant than those from wild-type mice to the cytotoxic effects of several alkylating agents. Moreover, an alkylation-resistant phenotype was observed in vivo using the BM micronucleus assay as a measure of chromosome damage. Flow cytometry indicated that in vivo alkylation resistance in Aag null BM cells may be restricted to cells of the myeloid lineage. These results show that in particular cell types, the initiation of base excision repair is more lethal to the cell than leaving the damaged bases unrepaired by Aag.




This article has been cited by other articles:


Home page
Proc. Natl. Acad. Sci. USAHome page
J. Shuga, J. Zhang, L. D. Samson, H. F. Lodish, and L. G. Griffith
In vitro erythropoiesis from bone marrow-derived progenitors provides a physiological assay for toxic and mutagenic compounds
PNAS, May 22, 2007; 104(21): 8737 - 8742.
[Abstract] [Full Text] [PDF]


Home page
Stem CellsHome page
D. J. Pearce, F. Anjos-Afonso, C. M. Ridler, A. Eddaoudi, and D. Bonnet
Age-Dependent Increase in Side Population Distribution Within Hematopoiesis: Implications for Our Understanding of the Mechanism of Aging
Stem Cells, April 1, 2007; 25(4): 828 - 835.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
N. Burns and B. Gold
The Effect of 3-Methyladenine DNA Glycosylase-Mediated DNA Repair on the Induction of Toxicity and Diabetes by the {beta}-Cell Toxicant Streptozotocin
Toxicol. Sci., February 1, 2007; 95(2): 391 - 400.
[Abstract] [Full Text] [PDF]


Home page
GeneticsHome page
J. Cairns
Cancer and the Immortal Strand Hypothesis
Genetics, November 1, 2006; 174(3): 1069 - 1072.
[Full Text] [PDF]


Home page
FASEB J.Home page
L. Tentori, C. Leonetti, M. Scarsella, A. Muzi, E. Mazzon, M. Vergati, O. Forini, R. Lapidus, W. Xu, A. S. Dorio, et al.
Inhibition of poly(ADP-ribose) polymerase prevents irinotecan-induced intestinal damage and enhances irinotecan/temozolomide efficacy against colon carcinoma
FASEB J, August 1, 2006; 20(10): 1709 - 1711.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
J. Paik, T. Duncan, T. Lindahl, and B. Sedgwick
Sensitization of Human Carcinoma Cells to Alkylating Agents by Small Interfering RNA Suppression of 3-Alkyladenine-DNA Glycosylase
Cancer Res., October 15, 2005; 65(22): 10472 - 10477.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
V. Simonelli, L. Narciso, E. Dogliotti, and P. Fortini
Base excision repair intermediates are mutagenic in mammalian cells
Nucleic Acids Res., August 2, 2005; 33(14): 4404 - 4411.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
R. N. Trivedi, K. H. Almeida, J. L. Fornsaglio, S. Schamus, and R. W. Sobol
The Role of Base Excision Repair in the Sensitivity and Resistance to Temozolomide-Mediated Cell Death
Cancer Res., July 15, 2005; 65(14): 6394 - 6400.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
L. Gros, A. V. Maksimenko, C. V. Privezentzev, J. Laval, and M. K. Saparbaev
Hijacking of the Human Alkyl-N-purine-DNA Glycosylase by 3,N4-Ethenocytosine, a Lipid Peroxidation-induced DNA Adduct
J. Biol. Chem., April 23, 2004; 279(17): 17723 - 17730.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. W. Sobol, M. Kartalou, K. H. Almeida, D. F. Joyce, B. P. Engelward, J. K. Horton, R. Prasad, L. D. Samson, and S. H. Wilson
Base Excision Repair Intermediates Induce p53-independent Cytotoxic and Genotoxic Responses
J. Biol. Chem., October 10, 2003; 278(41): 39951 - 39959.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
Q. Li, S. E. Wright, Z. Matijasevic, W. Chong, D. B. Ludlum, and M. R. Volkert
The role of human alkyladenine glycosylase in cellular resistance to the chloroethylnitrosoureas
Carcinogenesis, March 1, 2003; 24(3): 589 - 593.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
J. Cairns
Somatic stem cells and the kinetics of mutagenesis and carcinogenesis
PNAS, August 6, 2002; 99(16): 10567 - 10570.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2002 by the American Association for Cancer Research.